4/A//SEC Filing
Hornsby Todd 4/A
Accession 0000719135-23-000040
CIK 0000719135other
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 4:42 PM ET
Size
9.1 KB
Accession
0000719135-23-000040
Insider Transaction Report
Form 4/AAmended
Hornsby Todd
Executive Vice President
Transactions
- Sale
Common Stock
2023-06-26$7.56/sh−15,000$113,400→ 0 total - Exercise/Conversion
Common Stock
2023-06-26$1.77/sh+15,000$26,550→ 15,000 total - Exercise/Conversion
Stock Option (Option to Buy)
2023-06-26−15,000→ 20,000 totalExercise: $1.77From: 2019-12-18Exp: 2025-12-17→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The reported sale occurred automatically pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on March 21, 2023
- [F2]This transaction was executed in multiple trades at prices ranging from $7.30 to $7.70. The reported price in Column 4 is a weighted average price, rounded to the nearest hundredth. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The original Form 4 is hereby amended to correct the amount of securities beneficially owned by the Reporting Person (as set forth in Column 5 of Table I) following the previously reported transactions
Documents
Issuer
Apyx Medical Corp
CIK 0000719135
Entity typeother
Related Parties
1- filerCIK 0001764505
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 28, 8:00 PM ET
- Accepted
- Jun 29, 4:42 PM ET
- Size
- 9.1 KB